Monitoring efficiency of humoral rejection episode therapy in liver transplantation: any role for complement binding Luminex Single Antigen assays?

作者：Ducreux Stephanie^*; Guillaud Olivier; Bosch Alexie; Thaunat Olivier; Morelon Emmanuel; Hervieu Valerie; Mekki Yahia; Boillot Olivier; Scoazec Jean Yves; Dubois Valerie; Dumortier Jerome

来源：Transplant Immunology, 2016, 35: 23-28.

DOI：10.1016/j.trim.2016.01.007

• Liver transplantation
• Rejection
• Pregnancy
• Anti-HLA antibodies
• Complement-binding antibodies
• Therapy

Humoral rejection and its relationship with anti HLA antibodies have been extensively studied in organ transplantation with the exception of liver transplantation (LT). Recently, association between donor specific anti HLA antibodies (DSA) and increased risk of rejection and graft loss has been suggested in LT. When such antibodies appear, adequate treatment and monitoring are needed to avoid or delay allograft loss. We report here three cases of probable antibody-mediated rejection developed after pregnancy in liver transplanted women. Sera at the time of rejection and during follow-up have been retrospectively tested for the ability of DSA to bind complement components. These cases display different outcomes depending on the complement binding DSA capacity and titers after treatment of the rejection episodes. Thus, they highlight the potential interest of complement binding Luminex Single Antigen assays to monitor the efficiency of anti-rejection therapy.

• 出版日期2016-3